1)Schiefer U, Isbert M, Mikolaschek E et al:Distribution of scotoma pattern related to chiasmal lesions with special reference to anterior junction syndrome. Graefes Arch Clin Exp Ophthalmol 242:468-477, 2004
2)Roenne H:Ueber das Vorkommen eines hemianopischen zentralen Skotoms bei disseminierter Sclerose und retrobulbarer Neuritis. Klin Monatsbl Augenheilkd 50:446-448, 1912
3)Frohman LP, Frieman JP, Wolansky L:Reversible blindness resulting from optic chiasmitis secondary to systemic lupus erythematosus. J Neuroophthalmol 21:18-21, 2001
4)Beiran I, Krasnitz I, Zimhoni-Eibsitz M et al:Paediatric chiasmal neuritis-typical of post-Epstein-Barr virus infection? Acta Ophthalmol Scand 78:226-227, 2000
5)新井歌奈江・大平明彦・篠崎和美・他:Sjögren症候群に抗アクアポリン4抗体陽性視交叉部視神経炎を合併した1症例.あたらしい眼科27:1747-1751,2010
6)山本昇伯・木村 徹・武田哲郎・他:抗アクアポリン4抗体陽性であった視交叉炎の1例視野におけるoptic one and a half症候群.眼科52:1223-1229,2010
7)Lennon VA, Wingerchuk DM, Kryzer TJ et al:A serum autoantibody marker of neuromyelitis optica:distinction from multiple sclerosis. Lancet 324:2106-2112, 2004
8)Lennon VA, Kryzer TJ, Pittock SJ et al:IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473-477, 2005
9)中尾雄三:視神経炎アップデート“抗アクアポリン4抗体陽性視神経炎”.あたらしい眼科26:1329-1335,2009.
10)Kawasaki A, Purvin VA:Idiopathic chiasmal neuritis:clinical features and prognosis. Arch Ophthalmol 127:76-81, 2009
11)荻野展永・中馬秀樹・河野尚子・他:特発性視交叉炎の1例.眼科54:785-789,2012
12)Tradtrantip L, Zhang H, Saadoun S et al:Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol 71:314-322, 2012
13)中尾雄三・山本 肇・有村英子・他:抗アクアポリン4抗体陽性視神経炎の臨床的特徴.神経眼科25:327-342,2008
14)Venero JL, Vizuete ML, Ilundáin AA et al:Detailed localization of aquaporin-4 RNA in the CNS:preferential expression in periventricular organs. Neuroscience 94:239-250, 1999
15)三村 治・不二門尚・植木智志・他:抗アクアポリン4抗体陽性視神経炎診療ガイドライン.日眼会誌118:446-460,2014
16)Kim SH, Kim W, Huh SY et al:Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels. J Clin Neurol 9:36-42, 2013